Literature DB >> 8783419

Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography.

A Müller1, G Hein, S Franke, D Herrmann, S Henzgen, A Roth, G Stein.   

Abstract

The pyridinium crosslinks are important and definite biomarkers of mature hard tissue collagen degradation. A gradient ion-paired reversed-phase high-performance liquid chromatographic method was used for the simultaneous determination of both crosslinks in synovial fluid (SF) samples of 25 patients with rheumatoid arthritis (RA). The mean +/- SD levels of pyridinoline (Pyd) and deoxypyridinoline (Dpyd) in SF were 107.7 +/- 182.3 nmol/l and 4.8 +/- 8.3 nmol/l, respectively. The Pyd/Dpyd ratio, which indicates the amount of Pyd released from cartilage rather than bone, amounted to 30.8 +/- 29.5. This value is significantly higher than in urine or serum of the same patients. These data suggest increased destruction of joint cartilage in patients with RA and the release of collagen II fragments in SF. In addition, the levels of the crosslinks in SF reflect considerable interindividual variation, indicating substantial individual differences in the amount of collagenous material that is degraded.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783419     DOI: 10.1007/bf01419951

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  [Pyridinium cross-links in the urine. Specific markers of bone resorption in metabolic bone diseases].

Authors:  M J Seibel; A Zipf; R Ziegler
Journal:  Dtsch Med Wochenschr       Date:  1994-06-24       Impact factor: 0.628

2.  Synovial fluid concentration of five different cytokines in rheumatic diseases.

Authors:  C I Westacott; J T Whicher; I C Barnes; D Thompson; A J Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

3.  Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders.

Authors:  M Takahashi; K Kushida; T Ohishi; K Kawana; H Hoshino; A Uchiyama; T Inoue
Journal:  Arthritis Rheum       Date:  1994-05

4.  Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.

Authors:  L Sinigaglia; M Varenna; L Binelli; F Bartucci; M Arrigoni; R Ferrara; G Abbiati
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

5.  Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule.

Authors:  S P Robins; A Duncan
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

6.  Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline.

Authors:  S P Robins
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

7.  Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography.

Authors:  I James; C Crowley; D Perrett
Journal:  J Chromatogr       Date:  1993-01-29

8.  Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography.

Authors:  D R Eyre; T J Koob; K P Van Ness
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

9.  Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.

Authors:  A Colwell; R G Russell; R Eastell
Journal:  Eur J Clin Invest       Date:  1993-06       Impact factor: 4.686

10.  Synovial fluid and plasma levels of cartilage matrix glycoprotein in arthritis.

Authors:  R S Fife; J W Rachow; L M Ryan
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

View more
  7 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  Markers of joint destruction: principles, problems, and potential.

Authors:  S A Young-Min; T E Cawston; I D Griffiths
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.

Authors:  G Hein; S Franke; A Müller; E Bräunig; T Eidner; G Stein
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

4.  Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism.

Authors:  Peter Oelzner; Gabriele Lehmann; Thorsten Eidner; Sybille Franke; Andreas Müller; Gunter Wolf; Gert Hein
Journal:  Rheumatol Int       Date:  2006-01-11       Impact factor: 2.631

5.  The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.

Authors:  Peter Oelzner; Sybille Franke; Gabriele Lehmann; Thorsten Eidner; Gert Hein; Gunter Wolf
Journal:  Rheumatol Int       Date:  2010-09-07       Impact factor: 2.631

6.  Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.

Authors:  P Oelzner; S Franke; G Lehmann; T Eidner; A Müller; G Wolf; G Hein
Journal:  Clin Rheumatol       Date:  2007-05-31       Impact factor: 2.980

7.  Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study.

Authors:  Yoshiki Yoshihara; Tomoo Tsukazaki; Makoto Osaki; Masahiro Nakashima; Kazuhisa Hasui; Hiroyuki Shindo
Journal:  Arthritis Res Ther       Date:  2004-06-07       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.